BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 328017)

  • 1. [On the mechanism of action of valproid acid].
    Löscher W; Frey HH
    Arzneimittelforschung; 1977; 27(5):1081-2. PubMed ID: 328017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of convulsant and anticonvulsant agents on level and metabolism of gamma-aminobutyric acid in mouse brain.
    Löscher W; Frey HH
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Feb; 296(3):263-9. PubMed ID: 840320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of thyrotropin releasing hormone (TRH) on GABA (gamma aminobutyric acid) metabolism in mouse and rat brains: as to the activities of GAD (glutamic acid decarboxylase), GABA-T (GABA-transaminase) and GABA re-uptake].
    Kurahashi K; Kaneko S; Matsunaga M; Sato T; Takebe K
    No To Shinkei; 1985 Dec; 37(12):1211-6. PubMed ID: 3937548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiseizure activity of gamma-acetylenic gamma-aminobutyric acid: a catalytic irreversible inhibitor of gamma-aminobutyric acid transaminase.
    Schechter PJ; Tranier Y; Jung MJ; Sjoerdsma A
    J Pharmacol Exp Ther; 1977 Jun; 201(3):606-12. PubMed ID: 864598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of the cockroach brain gamma-aminobutyric acid system to isonicotinic acid hydrazide and mercaptopropionic acid.
    Pandey A; Singh R
    Biochem Int; 1985 Feb; 10(2):213-20. PubMed ID: 3994733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproic acid: brain and plasma levels of the drug and its metabolites, anticonvulsant effects and gamma-aminobutyric acid (GABA) metabolism in the mouse.
    Nau H; Löscher W
    J Pharmacol Exp Ther; 1982 Mar; 220(3):654-9. PubMed ID: 6801254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of gamma-aminobutyric acid (GABA)-elevating agents on the neuroleptic-induced activation of striatal tyrosine-hydroxylase: evidence that di-n-propylacetate augments GABAergic neurotransmission.
    Casu M; Gale K
    J Pharmacol Exp Ther; 1981 Apr; 217(1):177-80. PubMed ID: 6110774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proceedings: gamma-Aminobutyric acid metabolism and the anticonvulsant action of ethanolamine-o-sulphate and di-n-propylacetate.
    Anlezark GM; Horton RW; Meldrum BS; Sawaya MC; Stephenson JD
    Br J Pharmacol; 1976 Mar; 56(3):383P-384P. PubMed ID: 769882
    [No Abstract]   [Full Text] [Related]  

  • 9. Time course of the increase in GABA level in different mice brain regions following N-dipropylacetate treatment.
    Simler S; Gensburger C; Ciesielski L; Mandel P
    Commun Psychopharmacol; 1978; 2(2):123-30. PubMed ID: 352606
    [No Abstract]   [Full Text] [Related]  

  • 10. In vivo action of enzyme-activated irreversible inhibitors of glutamic acid decarboxylase and gamma-aminobutyric acid transaminase in retina vs. brain.
    Cubells JF; Blanchard JS; Smith DM; Makman MH
    J Pharmacol Exp Ther; 1986 Aug; 238(2):508-14. PubMed ID: 3735130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic inhibitors and subcellular distribution of GABA.
    Sarhan S; Seiler N
    J Neurosci Res; 1979; 4(5-6):399-421. PubMed ID: 392122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of the GABA-ergic link in the development of the tranquilizing effect in cats].
    Kozlovskaia MM; Kharlamov AN; Raevskiĭ KS; Val'dman AV
    Biull Eksp Biol Med; 1981; 91(1):45-8. PubMed ID: 6111364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticonvulsant and biochemical effects of inhibitors of GABA aminotransferase and valproic acid during subchronic treatment in mice.
    Löscher W
    Biochem Pharmacol; 1982 Mar; 31(5):837-42. PubMed ID: 6805473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticonvulsant action of ethanolamine-O-sulphate and di-n-propylacetate and the metabolism of gamma-aminobutyric acid (GABA) in mice with audiogenic seizures.
    Anlezark G; Horton RW; Meldrium BS; Sawaya CB
    Biochem Pharmacol; 1976 Feb; 25(4):413-7. PubMed ID: 779794
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibitors of GABA metabolism: implications for Huntington's disease.
    Schwarcz R; Bennett JP; Coyle JT
    Ann Neurol; 1977 Oct; 2(4):299-303. PubMed ID: 152600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Di-n-propylacetic acid--profile of anticonvulsant activity in mice.
    Frey HH; Löscher W
    Arzneimittelforschung; 1976 Feb; 26(2):299-301. PubMed ID: 779804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of repeated injections of GABA on the GABA shunt and various associated reactions in the rat brain].
    Rozanov VA; Karpovich GA; Sergeeva ON; Kopelevich VM; Gunar VI
    Vopr Med Khim; 1988; 34(1):29-33. PubMed ID: 3369124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of sodium n-dipropylacetate on the GABA level in various areas of the mouse brain].
    Simler S; Gensburger C; Ciesielski L; Mandel P
    C R Seances Soc Biol Fil; 1976; 170(6):1285-8. PubMed ID: 140750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of anticonvulsant activity of QUAN-0806 in various murine experimental seizure models.
    Guan LP; Zhao DH; Jiang Z; Piao HR; Quan ZS
    Pharmazie; 2009 Apr; 64(4):248-51. PubMed ID: 19435143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproic acid: metabolite concentrations in plasma and brain, anticonvulsant activity, and effects on GABA metabolism during subacute treatment in mice.
    Löscher W; Nau H
    Arch Int Pharmacodyn Ther; 1982 May; 257(1):20-31. PubMed ID: 6810778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.